Financial
FY2025 revenue €7.52bn (+7.0%); net margin 5.3%; net income €402.0m.
Net profit more than doubled; EBIT and leverage not captured.
Grifols
HQ Spain · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Fair
Customer rating
No reviews yet
Financial health
Band: FairListed: GRF.MC
FY2025 revenue €7.52bn (+7.0%); net margin 5.3%; net income €402.0m.
Net profit more than doubled; EBIT and leverage not captured.
Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | €7.5bn | +7.0% | — | €402m | Grifols |
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Aug 2025: Spain's securities regulator CNMV fined Grifols and several executives about €1.36m in total for inaccurate information in its 2021–2023 accounts and misleading performance measures, following short-seller Gotham City Research's 2024 allegations.
Cyber & information governance
No data breaches or cyber incidents involving Grifols found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Regulatory & clinical safety
Nov 2025: Grifols Therapeutics recalled one lot of Gammaked immune globulin in the US after a higher rate of allergic and hypersensitivity reactions, including a small number of medically significant cases. No diagnostics-specific actions found.
Contract performance
Jun 2025: NHS Blood and Transplant directly awarded Grifols UK a £131k (ex VAT) contract to supply 500ml cell media bottles. No disputes or terminations found in HSH's search of the last 24 months.
Competitors
No competitors linked yet.